Vividion Therapeutics
Bingwen Lu, Ph.D. is a seasoned Computational Biologist with extensive experience in the biopharmaceutical industry. Currently, Bingwen Lu serves at Vividion Therapeutics since October 2017. Prior to this role, Bingwen Lu worked at Pfizer for over seven years as a Principal Scientist. Bingwen Lu's academic foundation includes a post-doctoral fellowship at The Scripps Research Institute from September 2005 to June 2010, where critical research contributions were made.
This person is not in any teams
Vividion Therapeutics
2 followers
Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets.